Megestrol Acetate Oral Suspension — Class III drug recall D-0338-2018
Terminated recall by Mckesson Packaging Services, reported 2018-02-14, distributed nationwide. Subpotent Drug: Out of specification for assay (stability testing)
| Recall number | D-0338-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Packaging Services, Concord, NC, United States |
| Recall initiated | 2018-01-29 |
| Classified | 2018-02-08 |
| Reported by FDA | 2018-02-14 |
| Terminated | 2020-11-24 |
| Distributed | Nationwide (US) |
| Quantity | 24,120 cups |
| Reason classes | potency, specification failure |
| NDC | 63739-0549-51 |
| Lot numbers | 0114588, 10/18 |
Product
Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Reason for recall
Subpotent Drug: Out of specification for assay (stability testing)
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0338-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.